[1]
P. Carratù, S. Dragonieri, and O. Resta, “Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial”, Swiss Med Wkly, vol. 149, no. 3940, p. w20132, Sep. 2019.